Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine

Cephalalgia

Volumn 26, Issue 3, 2006, Pages 246-256

  Lainez M J A ^a   Evers, S ^b   Kinge, E ^c   Allais, G ^d   Allen, C ^e   Rao, N A ^e   Massaad, R ^e   Lis, K ^e  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Sandvika Neurologic Service   (Norway)

^d UNIVERSITY OF TURIN   (Italy)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

5 HT1B 1D receptor agonist; Eletriptan; Migraine; Patient preference; Rizatriptan wafer

Indexed keywords

ELETRIPTAN; RIZATRIPTAN;

ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; EVALUATION; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; STOMACH DISEASE; THORAX PAIN; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SATISFACTION; PYRROLIDINES; SEROTONIN AGONISTS; TABLETS; TIME FACTORS; TRIAZOLES; TRYPTAMINES;

EID: 33645036615     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.00991.x     Document Type: Article

References (19)

1. Goadsby PJ Lipton RB Ferrari MD Migraine - current understanding and treatment N Engl J Med 2002 346 257 70
2. 1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials Cephalalgia 2002 22 633 58
3. 1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials Lancet 2001 358 1668 75
4. Tfelt-Hansen P Teall J Rodriguez F Gracorazzo M Paz J Malbecq W et al. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group Headache 1998 38 748 55
5. Kramer MS Matzura-Wolfe D Polis A Getson A Amaraneni PG Solbach MP et al A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks Neurology 1998 51 773 81
6. Block GA Goldstein J Polis A Reines SA Smith ME and the Rizatriptan Multicenter Study Groups. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine Headache 1998 38 764 71
7. Ahrens SP Farmer MV Williams DL Willoughby E Jiang K Block GA Visser WH Efficacy and safety of rizatriptan wafer for the acute treatment of migraine Cephalalgia 1999 19 525 30
8. Adelman JU Mannix LK Von Seggern RL Rizatriptan tablet versus wafer: patient preference Headache 2000 40 371 2
9. Stark R Dahlof C Haughie S Hettiarachchi J on behalf of the Eletriptan Steering Committee. Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks Cephalalgia 2002 22 23 32
10. Loder E Brandes JL Silberstein S Skobieranda F Bohidar N Wang L et al Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine Headache 2001 41 745 53
11. Pascual J Bussone G Hernandez JF Allen C Vrijens F Patel K Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine Eur Neurol 2001 45 275 83
12. Christie S Göbel H Mateos V Allen C Vrijens F Shivaprakash M et al Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine Eur Neurol 2003 49 20 9
13. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain Cephalalgia 1988 8 Suppl. 7 1 96
14. Jones B Kenward G Design and analysis of cross-over trials London Chapman & Hall 1989
15. Kalbfleish JD Prentice RL Marginal likelihood based on Cox's regression life models Biometrika 1973 60 267 8
16. Lipton RB Stewart WF Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 1999 39 Suppl. 2 S20 S26
17. Silberstein SD Migraine symptoms: results of a survey of self-reported migraineurs Headache 1995 35 387 96
18. Davies GM Santanello N Lipton R Determinants of patient satisfaction with migraine therapy Cephalalgia 2000 20 554 60
19. Lipton RB Hamelsky SW Dayno JM What do patients with migraine want from acute migraine treatment? Headache 2002 42 Suppl. 1 3 9